126650DF4 Competition

126650DF4

94.64 2.25 2.32%

Specify up to 10 symbols:

Low	Estimated	High
94.28	94.64	95.00

Details

Intrinsic

Valuation

Low	Real	High
85.18	95.04	95.40

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as 126650DF4. Your research has to be compared to or analyzed against 126650DF4's peers to derive any actionable benefits. When done correctly, 126650DF4's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in CVS HEALTH P.

126650DF4 Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between 126650DF4 and its competitors represents the degree of relationship between the price movements of corresponding bonds. A correlation of about +1.0 implies that the price of 126650DF4 and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of CVS HEALTH P does not affect the price movement of the other competitor.

	TSM	TSEM	GFS	IPGP	VMD	ELTTF	TFX
TSM		0.54	-0.08	0.82	0.87	0.0	-0.48	TSM
TSEM	0.54		0.35	0.47	0.59	0.0	-0.58	TSEM
GFS	-0.08	0.35		0.05	0.05	0.0	-0.32	GFS
IPGP	0.82	0.47	0.05		0.75	0.0	-0.58	IPGP
VMD	0.87	0.59	0.05	0.75		0.0	-0.6	VMD
ELTTF	0.0	0.0	0.0	0.0	0.0		0.0	ELTTF
TFX	-0.48	-0.58	-0.32	-0.58	-0.6	0.0		TFX
	TSM	TSEM	GFS	IPGP	VMD	ELTTF	TFX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

VMD	+ 0.87	TSM
IPGP	+ 0.82	TSM
VMD	+ 0.75	IPGP
VMD	+ 0.59	TSEM
TSEM	+ 0.54	TSM
IPGP	+ 0.47	TSEM

High negative correlations

TFX	- 0.6	VMD
TFX	- 0.58	IPGP
TFX	- 0.58	TSEM
TFX	- 0.48	TSM
TFX	- 0.32	GFS
GFS	- 0.08	TSM

Risk-Adjusted Indicators

There is a big difference between 126650DF4 Bond performing well and 126650DF4 Corporate Bond doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze 126650DF4's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
TSM	1.87	0.04	0.00	0.17	2.31	(1.94)	4.13	(4.21)	14.10
TSEM	1.82	(0.01)	0.02	0.11	2.66	(1.72)	3.85	(3.78)	16.72
GFS	2.27	(0.39)	0.00	(0.02)	0.00	0.00	4.70	(4.20)	18.30
IPGP	1.68	(0.01)	0.03	0.11	1.86	(1.78)	4.46	(3.32)	11.69
VMD	1.51	0.09	0.06	0.19	1.67	(1.62)	3.30	(2.76)	10.98
ELTTF	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
TFX	1.18	(0.42)	0.00	(0.41)	0.00	0.00	1.71	(1.92)	17.00

Unable to evaluate fundamental data of [TSM, TSEM, GFS, IPGP, VMD, ELTTF, TFX] at this time. Please try again later

All Fundamental Data

126650DF4 Competitive Analysis

The better you understand 126650DF4 competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, 126650DF4's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across 126650DF4's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	126650DF4	TSM	TSEM	GFS	IPGP	VMD	ELTTF	TFX
	2.32 94.64 126650DF4	1.92 184.66 Taiwan	0.49 47.13 Tower	0.93 43.25 Globalfoundries	0.96 78.04 IPG	1.29 8.67 Viemed	0.00 89.23 Elmos	0.44 192.85 Teleflex
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Very steady	Very steady	Very steady	Not too volatile	Very steady	Very steady
Market Performance (90 Days Performance)	Very Weak	OK	OK	Weak	OK	OK	Very Weak	Very Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Below Average	Very Low	Very Low	Very Low	Below Average	Low	Unknown	Very Low
Current Valuation (Equity Enterprise Value)	Fairly Valued	Over Valued	Over Valued	Under Valued	Under Valued	Under Valued	Fairly Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Strong Buy	Strong Buy	Buy	Buy	Strong Buy	Not Available	Buy
Trade Advice (90 Days Macroaxis Advice)	Strong Hold	Strong Buy	Strong Buy	Strong Buy	Strong Buy	Strong Buy	Strong Buy	Strong Buy
Current Ratio	N/A	2.49 X	3.81 X	1.66 X	6.87 X	2.34 X		2.39 X
Net Asset	N/A	5.53 T	2.92 B	18.04 B	2.7 B	154.9 M		7.53 B
Profit Margin	N/A	0.39 %	0.36 %	0.11 %	(0.14) %	0.05 %		0.08 %
EBITDA	N/A	1.45 T	851.12 M	2.64 B	301.19 M	36.71 M		743.74 M
Operating Margin	N/A	0.47 %	0.14 %	0.11 %	(0.12) %	0.09 %		0.20 %
Current Valuation	N/A	742.23 B	4.29 B	23.05 B	2.34 B	329.21 M		10.54 B
Price To Book	N/A	7.64 X	2.01 X	2.10 X	1.58 X	2.67 X		1.99 X
Retained Earnings	N/A	2.88 T	467.62 M	(13 B)	2.8 B	79.5 M		4.11 B
Five Year Return	N/A	2.64 %	N/A	N/A	N/A	N/A		0.44 %
Current Asset	N/A	N/A	446.73 M	N/A	1.12 B	N/A		1 B
Beta	N/A	1.23	0.9	1.53	0.99	1.44		1.18
Number Of Employees	N/A	N/A	N/A	12 K	6.18 K	1.14 K		14.5 K
Shares Outstanding	N/A	5.19 B	111.07 M	552.65 M	43.25 M	38.94 M		46.44 M
Cash Flow From Operations	N/A	1.24 T	676.56 M	2.12 B	295.99 M	45.21 M		510.64 M
Annual Yield	N/A	0.02 %	N/A	N/A	N/A	N/A		0.01 %
Total Debt	N/A	959.07 B	231.56 M	2.75 B	18.26 M	10.32 M		1.93 B
Return On Equity	N/A	0.28	0.22	0.0665	-0.0658	0.0888		0.0541
Return On Asset	N/A	0.12	0.0402	0.0287	0.0074	0.0686		0.0315
Number Of Shares Shorted	N/A	30.84 M	1.24 M	13.25 M	1.64 M	291.18 K		675.04 K
Book Value Per Share	N/A	153.89 X	21.95 X	20.87 X	48.90 X	3.21 X		96.50 X
Current Liabilities	N/A	N/A	211.12 M	N/A	144.98 M	N/A		664.12 M
Total Asset	N/A	5.53 T	2.92 B	18.04 B	2.7 B	154.9 M		7.53 B
Debt To Equity	N/A	0.31 %	0.17 %	0.30 %	0.01 %	0.06 %		0.46 %
Short Ratio	N/A	1.89 X	3.02 X	6.03 X	5.87 X	1.37 X		1.44 X
Target Price	N/A	229.96	57.5	48.6	86.17	12.27		245.01
Last Dividend Paid	N/A	15.5	N/A	N/A	N/A	N/A		1.36
Shares Owned By Institutions	N/A	16.42 %	63.20 %	100.00 %	60.37 %	66.67 %		99.76 %
Market Capitalization	N/A	939.75 B	5.26 B	24.38 B	3.34 B	333.3 M		8.92 B
Price To Earning	N/A	21.27 X	58.09 X	56.10 X	29.75 X	29.88 X		38.28 X
Price To Earnings To Growth	N/A	1.16 X	0.90 X	1.66 X	2.52 X	N/A		0.98 X
Price To Sales	N/A	0.35 X	3.79 X	3.60 X	3.21 X	1.56 X		2.95 X
Net Income	N/A	979.32 B	518.49 M	1.02 B	218.88 M	10.24 M		356.33 M
Earnings Per Share	N/A	6.25 X	1.84 X	1.28 X	(3.33) X	0.25 X		5.05 X
Shares Owned By Insiders	N/A	N/A	N/A	N/A	39.87 %	12.63 %		0.28 %
Revenue	N/A	2.16 T	1.42 B	7.39 B	1.29 B	183.01 M		2.97 B
Working Capital	N/A	1.25 T	1.43 B	3.23 B	1.7 B	6.24 M		800.66 M
Cash And Equivalents	N/A	13.52 B	855.96 M	3 B	1.23 B	21.92 M		292.03 M
Cash Per Share	N/A	7.23 X	7.83 X	5.55 X	24.59 X	0.57 X		9.08 X
Gross Profit	N/A	1.35 T	466.31 M	2.24 B	555.41 M	84.68 M		1.55 B
Day Typical Price	94.64	184.26	47.03	43.17	77.92	8.62	89.23	192.44
Accumulation Distribution	N/A	248309.0	7473.94	18259.64	2459.37	1145.25	N/A	4907.71
Daily Balance Of Power	(9,223,372,036,855)	0.6014	(0.24)	0.4301	0.4512	0.6875	0.0	0.3587
Period Momentum Indicator	(2.25)	3.47	(0.23)	0.4	0.74	0.11	N/A	0.85
Rate Of Daily Change	0.98	1.02	1.0	1.01	1.01	1.01	1.0	1.0
Day Median Price	94.64	184.07	46.98	43.13	77.86	8.59	89.23	192.24
Price Action Indicator	(1.12)	2.33	0.035	0.32	0.55	0.13	N/A	1.04
Coefficient Of Variation	(2,023)	1981.97	1447.08	(6,693)	1163.0	826.38	N/A	(680.62)
Mean Deviation	0.3422	1.87	1.82	2.27	1.68	1.51	N/A	1.18
Jensen Alpha	(0.04)	0.0394	(0.01)	(0.39)	(0.01)	0.0893	N/A	(0.42)
Total Risk Alpha	(0.18)	(0.27)	(0.24)	(0.59)	(0.16)	(0.07)	N/A	(0.66)
Sortino Ratio	N/A	0.0017	0.0223	N/A	0.0336	0.0639	N/A	N/A
Downside Variance	N/A	5.83	8.8	N/A	4.29	3.37	N/A	N/A
Standard Deviation	0.8331	2.57	2.77	3.5	2.27	2.0	N/A	2.19
Kurtosis	13.26	2.56	5.57	7.02	1.04	1.46	N/A	27.77
Potential Upside	0.7858	4.13	3.85	4.7	4.46	3.3	N/A	1.71
Treynor Ratio	0.5062	0.1722	0.1083	(0.02)	0.1087	0.1873	N/A	(0.41)
Maximum Drawdown	6.21	14.1	16.72	18.3	11.69	10.98	N/A	17.0
Variance	0.6941	6.58	7.69	12.23	5.14	4.02	N/A	4.77
Market Risk Adjusted Performance	0.5162	0.1822	0.1183	(0.01)	0.1187	0.1973	N/A	(0.40)
Risk Adjusted Performance	(0.04)	0.0457	0.0602	(0)	0.0725	0.0989	N/A	(0.11)
Skewness	(1.68)	0.6002	0.7447	1.75	0.5607	0.5759	N/A	(4.09)
Semi Deviation	N/A	2.31	2.66	N/A	1.86	1.67	N/A	N/A
Information Ratio	(0.20)	0.0016	0.0239	(0.05)	0.0307	0.0585	N/A	(0.20)
Value At Risk	(0.74)	(4.21)	(3.78)	(4.20)	(3.32)	(2.76)	N/A	(1.92)
Expected Short fall	N/A	(1.94)	(1.72)	N/A	(1.78)	(1.62)	N/A	N/A
Downside Deviation	N/A	2.41	2.97	N/A	2.07	1.83	N/A	N/A
Semi Variance	N/A	5.33	7.08	N/A	3.46	2.79	N/A	N/A

126650DF4 Competition Performance Charts

Five steps to successful analysis of 126650DF4 Competition

126650DF4's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by CVS HEALTH P in relation to its competition. 126650DF4's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of 126650DF4 in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact 126650DF4's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to CVS HEALTH P, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your 126650DF4 position

In addition to having 126650DF4 in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Construction Materials Thematic Idea Now

Construction Materials

Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Construction Materials theme has 61 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Construction Materials Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in 126650DF4 Bond

126650DF4 financial ratios help investors to determine whether 126650DF4 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 126650DF4 with respect to the benefits of owning 126650DF4 security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC